Your browser doesn't support javascript.
loading
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.
van den Reek, J M P A; Zweegers, J; Kievit, W; Otero, M E; van Lümig, P P M; Driessen, R J B; Ossenkoppele, P M; Njoo, M D; Mommers, J M; Koetsier, M I A; Arnold, W P; Sybrandy-Fleuren, B A M; Kuijpers, A L A; Andriessen, M P M; van de Kerkhof, P C M; Seyger, M M B; de Jong, E M G J.
Affiliation
  • van den Reek JM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Br J Dermatol ; 171(5): 1189-96, 2014 Nov.
Article in En | MEDLINE | ID: mdl-24807471
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Immunoglobulin G / Receptors, Tumor Necrosis Factor / Dermatologic Agents / Antibodies, Monoclonal, Humanized Type of study: Observational_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2014 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Immunoglobulin G / Receptors, Tumor Necrosis Factor / Dermatologic Agents / Antibodies, Monoclonal, Humanized Type of study: Observational_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2014 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido